1248218

Erythropoietin

United States Pharmacopeia (USP) Reference Standard

• Formule empirique (notation de Hill) : C₈₀₉H₁₃₀₁N₂₂₉O₂₄₀S₅
• Numéro CAS: 113427-24-0
• Poids moléculaire : 18235.70
• MDL number: MFCD00015392
• NACRES: NA.24
• UNSPSC Code: 41116107

Propriétés

• grade: pharmaceutical primary standard
• agency: USP
• API family: erythropoietin
• form: solid
• manufacturer/tradename: USP
• application(s): USP Biologics; pharmaceutical

Description

General description

Erythropoietin (EPO) is a glycoprotein hormone produced by the kidneys to regulate red blood cell production. Recombinant EPO is used in treating anemia due to chronic kidney disease or chemotherapy. The USP standard supports bioidentity and potency testing using validated cell-based assays.

The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application

Erythropoietin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Epoetin

Other Notes

This product is part of the USP Biologics program.

Informations sur la sécurité

• Classe de stockage: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable